Fertility Institute of New Jersey and New York

What the CDC NASS Data Shows for Fertility Institute of New Jersey and New York

Fertility Institute of New Jersey and New York reported cycle outcomes to the CDC National ART Surveillance System for the 2022 reporting year, with 3 years of cumulative reporting history. The clinic performed 497 total ART cycles, split between 23 fresh and 474 frozen embryo transfer cycles. The overall success rate — live births per cycle started — was 41.9%. That is 7.7 percentage points above the New Jersey state average of 34.2%.

Age remains the dominant variable in IVF outcomes. At Fertility Institute of New Jersey and New York, patients under 35 saw a 65.1% success rate, compared with 53.6% for ages 35–37 and 30.1% for ages 38–40. The over-40 cohort reported 12.7%. Single embryo transfer (SET) was used in 56.6% of cycles, a metric ASRM associates with lower multi-pregnancy rates.

Service availability also affects which clinics fit which patients. Fertility Institute of New Jersey and New York does report donor egg services and does offer gestational carrier (surrogate) cycles. These services matter for patients with diminished ovarian reserve, same-sex couples, or medical conditions that preclude carrying a pregnancy. Every figure above is a public federal disclosure, not editorial commentary — PlainFertility is not affiliated with Fertility Institute of New Jersey and New York or the CDC, and these statistics are not a substitute for an evaluation by a board-certified reproductive endocrinologist who can assess your individual diagnosis, history, and treatment options.

Read these figures as a starting point, not a verdict. The CDC reports live births per intended egg retrieval, so the percentages already account for cycles that never reached embryo transfer — a more conservative measure than the per-transfer pregnancy rates clinics sometimes advertise. Group results describe what happened for past patients; they cannot predict an individual outcome, which depends on diagnosis, ovarian reserve, sperm quality, embryo genetics, and the protocol a physician recommends. A single reporting year can swing for lower-volume clinics, so cumulative multi-year results and a candid consultation carry more weight than any one published number.